A Cambridge-based innovator in gallium nitride power devices has closed a $32m Series C funding round led by a strategic investor with participation from British Patient Capital.
Cambridge GaN Devices (CGD), a leading innovator in gallium nitride (GaN) power devices, has successfully closed a $32million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback